Skip to content Skip to footer

COVID-19 Vaccine Clinical Trial

Exploring a New COVID-19 Vaccine Option for Adults

Interested in Advancing COVID-19 Vaccine Research?

Take the Next Step in Advancing COVID-19 Vaccine Research.

COVID-19 is a contagious respiratory illness caused by the SARS-CoV-2 virus that can cause symptoms such as fever, cough, sore throat, tiredness, headaches, and breathing difficulties. Some people may only experience mild cold-like symptoms, while others can develop serious illness that affects their lungs, energy levels, and overall well-being. In certain cases, recovery can take weeks or even months, and some individuals may continue to experience lingering effects long after the infection has passed.

Although testing, treatment options, and awareness have improved over time, COVID-19 still impacts communities across the country. New infections continue to occur each year, reminding us that the virus has not disappeared. For this reason, researchers continue to study new vaccines that may offer improved or longer-lasting protection.

Revival Research Institute is conducting a COVID-19 Vaccine clinical trial to evaluate an investigational COVID-19 vaccine in adults. This covid vaccine research study aims to understand how well the new vaccine works and how the body responds after vaccination.

Are You Eligible to Participate?

To qualify for the COVID-19 Vaccine Clinical Trial, participants must:
*Additional Criteria may apply
Participation in the COVID-19 Vaccine Clinical Trials is free of cost. To learn more or enroll, fill out the form. A member of our research team will contact you to discuss your potential eligibility for the study.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
This is our Privacy Policy.

COVID-19 Vaccine Clinical Trial Flyer

About the Clinical Trials for COVID-19 Vaccines

COVID-19 continues to affect people in different ways, and many communities still experience new cases each year. Even with improved treatments, the virus can lead to serious illness, especially in adults who have not been vaccinated before. Getting sick can disrupt daily life, impact overall health, and place individuals at greater risk for complications.

Revival Research Institute is conducting a clinical research study to evaluate the safety and effectiveness of an investigational vaccine aimed at reducing the risk of infection and supporting stronger protection against the virus.

Clinical Trials for COVID-19 Vaccine will be conducted in several locations across the United States, including Michigan. To ensure study eligibility, all participants must comply with all study procedures. Participants who meet the eligibility criteria after undergoing the screening phase and are chosen to participate may receive either the investigational vaccine or a placebo.

*All study-related procedures and treatments—including the study treatments—are provided at no cost. No insurance is required to participate, and eligible participants may receive compensation for time and travel.

*To take the next step, complete the form above. A member from our research team will contact you to determine if you qualify. A brief discussion about your health and medical history may be required.

Get Started
What to Expect?

If you are interested in contributing to COVID-19 vaccine development, you may qualify for a paid clinical trial evaluating an investigational COVID-19 vaccine. After completing the interest form above, a member of our research team will contact you for a brief pre-screening to determine if you meet the initial eligibility criteria.

If you qualify, you’ll be asked to review and sign an Informed Consent Form (ICF), which outlines all study procedures, potential benefits, and possible risks. Once consent is given, you will be invited to one of Revival’s research sites for a screening visit. During this visit, we will review your medical history, conduct physical exams, and perform lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the COVID-19 Vaccine Clinical Trial.

Our team is committed to ensuring you fully understand your role in the study and what to expect throughout. Please feel free to ask any questions before deciding to participate. Your involvement helps advance future treatment options for COVID-19.

Age Icon
Age
50 – 64 years
Condition Icon
Condition
Healthy Participants
Location Icon
Location
Michigan

Understanding COVID-19

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. It spreads primarily through respiratory droplets and can lead to a wide range of symptoms, including fever, cough, sore throat, fatigue, headaches, and shortness of breath. While some individuals experience mild symptoms similar to a common cold, others may face more severe complications that impact lung function and overall health.

The effects of COVID-19 can vary greatly from person to person. Some recover quickly, while others may require extended time to regain their strength. In certain cases, symptoms can persist well beyond the initial infection, affecting daily activities and quality of life.

COVID-19 Risk Factors May Include

Common Symptoms of COVID-19 May Include

Frequently Asked Questions

Your Guide to COVID-19

Got questions about COVID-19? You’re not alone.

We’ve compiled answers to some of the most common questions about the condition—what causes it, how it’s treated, and what daily life with COVID-19 can look like. Still can’t find what you’re looking for? Our team is here to help. Reach out to us on +1 (248) 721-9539, and we’ll be happy to assist you.

COVID-19 is a viral illness that affects the respiratory system and can cause symptoms ranging from mild cold-like signs to severe breathing problems.
Vaccines help reduce the risk of severe illness. This clinical trial is studying a new investigational vaccine to learn how well it may protect adults.
Without adequate protection, COVID-19 can lead to complications such as pneumonia, long-term fatigue, heart issues, or hospitalization.
No, insurance is not required to take part in this clinical trial. All study-related treatments and procedures are provided at no cost.
By enrolling in clinical trials for COVID-19 vaccine, access an investigational vaccine, receive expert medical care, and contribute to advancing research.